Content about Muscle relaxants

June 13, 2012
Merck releases positive phase-3 data regarding promising insomnia remedy suvorexant

Merck on Wednesday released new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia.

September 1, 2011
FDA approves Sagent drug

The Food and Drug Administration has approved a generic skeletal muscle relaxant made by Sagent Pharmaceuticals, Sagent said.

August 19, 2011
Sagent launches neuromuscular disorder drug

Generic drug maker Sagent Pharmaceuticals has launched a new drug for neuromuscular disorders, the company said.

© 2013 Drug Store News. All Rights Reserved.